An Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has Spread
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Sjogrens Syndrome Measured by Ultrasound
- Status
- UNKNOWN
- Phase
- PHASE2
Elotuzumab Plus Lenalidomide (Elo/Rev) for Serologic Relapse/Progression While on Lenalidomide
- Status
- TERMINATED
- Phase
- PHASE2
Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase IIb Study Evaluating Immunogenic Chemotherapy Combined with Ipilimumab and Nivolumab in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)
- Status
- COMPLETED
- Phase
- PHASE1
Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)
- Status
- TERMINATED
- Phase
- PHASE2
Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Niraparib + Ipilimumab or Nivolumab in Progression Free Pancreatic Adenocarcinoma After Platinum-Based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism
- Status
- COMPLETED
- Phase
- N/A
A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Sub-study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
- Status
- COMPLETED
- Phase
- PHASE2
Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy
- Status
- COMPLETED
- Phase
- PHASE1
An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck
- Status
- WITHDRAWN
- Phase
- PHASE3
A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
SBRT With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung Effects
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nivolumab and Bevacizumab in Patients With Advanced and or Metastatic Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1